Sørbye H, Berglund Åke, Magne Tveit K, Øgreid D, Hoff Wanderås E, Wentzel-Larsen T, et al. Secondary treatment and predictive factors for second-line chemotherapy after first-line oxaliplatin-based therapy in metastatic colorectal cancer. AO [Internet]. 2007 Jan. 1 [cited 2026 Jun. 30];46(7):982-8. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/26541